Late Results of Percutaneous Mitral Commissurotomy in a Series of 1024 Patients

Author:

Iung Bernard1,Garbarz Eric1,Michaud Pierre1,Helou Steeven1,Farah Bruno1,Berdah Patricia1,Michel Pierre-Louis1,Cormier Bertrand1,Vahanian Alec1

Affiliation:

1. From the Cardiology Department, Tenon Hospital, Paris, France.

Abstract

Background —The optimal use of percutaneous mitral commissurotomy (PMC) in a wide range of patients requires accurate evaluation of late results and identification of their predictors. Methods and Results —Late results of PMC were assessed in 1024 patients whose mean age was 49±14 years. Echocardiography showed that 141 patients (14%) had pliable valves and mild subvalvular disease, 569 (55%) had extensive subvalvular disease, and 314 (31%) had calcified valves. A single balloon was used in 26 patients, a double balloon in 390, and the Inoue Balloon in 608. Good immediate results were defined as valve area ≥1.5 cm 2 without regurgitation >2/4 (Sellers’ grade) and were obtained in 912 patients. Median duration of follow-up was 49 months. The 10-year actuarial rate of good functional results (survival with no cardiovascular death and no need for surgery or repeat dilatation and in New York Heart Association [NYHA] class I or II) was 56±4% in the entire population. Follow-up echocardiography was available in 90% of the patients who experienced poor functional results after good immediate results and showed restenosis in 97% of these. In multivariate analysis, the predictors of poor functional results were old age ( P =0.0008), unfavorable valve anatomy ( P =0.003), high NYHA class ( P <0.0001), atrial fibrillation ( P <0.0001), low valve area after PMC ( P =0.001), high gradient after PMC ( P <0.0001), and grade 2 mitral regurgitation after PMC ( P =0.04). Conclusions —PMC can be performed with good late results in a variety of patient subsets. Prediction of late events is multifactorial. Knowledge of these predictors can improve patient selection and follow-up.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3